期刊文献+

肺纤维化的药物治疗进展 被引量:3

下载PDF
导出
摘要 肺纤维化发生在许多肺部疾病如间质性肺炎、结缔组织疾病引起的肺部并发症、急性呼吸窘迫综合征(ARDS)等,其发生往往是预后不佳的表现之一。肺纤维化的治疗比较困难,目前研究发现,某些药物如吡非尼酮、伊马替尼、γ干扰素等具有抗纤维化作用,有望用于肺纤维化治疗。
作者 蔡颖
出处 《世界临床药物》 CAS 2008年第1期17-19,共3页 World Clinical Drug
  • 相关文献

参考文献10

  • 1Lurton JM,Trejo T,Narayanan AS,et al.Pirfenidone inhibits the stimulatory effects of profibrotic cytokines on human lung fibroblasts in vitro[].American Journal of Respiratory and Critical Care Medicine.1996
  • 2Raghu G,Johnson WC,Lockhart D,et al.Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone:results of a prospective,open-label PhaseⅡstudy[].American Journal of Respiratory and Critical Care Medicine.1999
  • 3Simone NL,Soule BP,Gerber L,et al.Oral Pirfenidone in patients with chronic fibrosis resulting from radiotherapy:a pilot study[].Radiotherapy and Oncology.2007
  • 4Azuma A,Nukiwa T,Tsuboi E,et al.Double-blind,placebo- controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis[].American Journal of Respiratory and Critical Care Medicine.2005
  • 5Aono Y,Nishioka Y,Inayama M,et al.Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice[].The Journal of Experimental Medicine.2005
  • 6Vuorinen K,Gao F,Oury TD,et al.Imatinib mesylate inhibits fibrogenesis in asbestos-induced interstitial pneumonia[].Experimental Lung Research.2007
  • 7Tzortzaki EG,Antoniou KM,Zervou MI,et al.Effects of antifibrotic agents on TGF-betal,CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis[].Respiratory Medicine.2007
  • 8Bajwa EK,Ayas NT,Schulzer M,et al.Interferon-gamma1b therapy in idiopathic pulmonary fibrosis:a metaanalysis[].Chest.2005
  • 9Nathan SD,Barnett SD,Moran B,et al.Interferon gamma-1b as therapy for idiopathic pulmonary fibrosis.An intrapatient analysis[].Respiration.2004
  • 10Raghu G,Brown KK,Bradford WZ,et al.A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis[].The New England Journal of Medicine.2004

同被引文献89

  • 1蒋瑛,高彦荣.甲磺酸伊马替尼治疗骨髓纤维化[J].医学综述,2005,11(2):181-182. 被引量:2
  • 2洪阁,刘培勋.槐属植物生物碱化学成分及药理作用研究进展[J].中草药,2005,36(5):783-788. 被引量:31
  • 3马洪兵,邓承祺.伊马替尼在Ph-的慢性骨髓增殖性疾病中的应用[J].国外医学(输血及血液学分册),2005,28(5):436-438. 被引量:1
  • 4Miachael C, Surrenti C, Milani S. Trans forming growth factors beta1 And beta2 are differentially expresse dinfibroticliv erdisease. Bone JointSurge, 1991, (73) : 1418.
  • 5Toshikazu Nakamura, Katsuhiko Nawa and Akira Ichihara. Partial Purification and Characterization of Hepatocyte Growth Factor from Serum of Hepatectomized Rats. Biochemical and Biophysical Research Communications, 1984, ( 3 ) : 1450-1459.
  • 6Toshikazu Nakamura, Tsutomu Nishizawa, Mitchio Hagiya et al. Molecular cloning and expression of human hepatocyte growth factor. Letters To Nature, 1989 (23) :440-442.
  • 7Noji S, Tashiro K, Koyama E, et al. Expression of hepatocyte growth factor gene in endothelial and kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun, 1990,173 ( 1 ) :42-47.
  • 8Ramadori G, Neubauer K, Odenthal M, et al. The gene of hepatocyte growth factor is expressed in fat-storing cells of rat liver and is down regulated during cell growth and by transforing growth factor beta. Biochem Biophys Res Commun, 1992,183(2) :739-742.
  • 9Nishino T, Kaise N, Sindo Y, et al. Promyelocytic leukemia cell line, HL-60, produces human hepatocyte growth factor. Biochem Biophys Res Commun, 1991 ; 181 ( 1 ) :323-330.
  • 10Yoshinaga Y, Fujita S, Gotoh M, et al. Human lung cancer cell line producing hepatocyte growth factor/scatter factor. Jpn J Cancer Res, 1992,83 (12) : 1257-1261.

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部